Dialogues in Clinical Neuroscience

Dialogues in Clinical Neuroscience

DIALOGUES CLIN NEURO
影响因子:8.9
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:FRANCE
出版社:Servier International
发刊时间:0
发刊频率:
收录数据库:SCIE/Scopus收录
ISSN:1294-8322

期刊介绍

Dialogues in Clinical Neuroscience is a quarterly publication that aims to serve as an interface between clinical neuropsychiatry and the neurosciences by providing state-of-the-art information and original insights into relevant clinical, biological, and therapeutic aspects. Each issue addresses a specific topic, and authors are invited by the Editorial Board. All contributions are reviewed by members of the Editorial Board and submitted to expert consultants for peer review.
《临床神经科学对话》 (Dialogues in Clinical Neuroscience )是一份季刊,旨在通过提供最新信息和对相关临床、生物学和治疗方面的独到见解,作为临床神经精神病学和神经科学之间的接口。每一期都涉及一个特定的主题,作者由编辑委员会邀请。所有稿件均由编辑委员会成员审查,并提交给专家顾问进行同行审查。
年发文量 9
国人发稿量 0
国人发文占比 0%
自引率 -
平均录取率-
平均审稿周期 -
版面费 -
偏重研究方向 Medicine-Psychiatry and Mental Health
期刊官网 https://www.dialogues-cns.org/
投稿链接

期刊高被引文献

Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer’s disease\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/hhampel
Unraveling the epigenetic landscape of depression: focus on early life stress\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.4/enestler
A review of epigenetic contributions \u2028to post-traumatic stress disorder\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.4/kressler
Domains of cognition and their assessment\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/pharvey
Dietary interventions in mild cognitive impairment and dementia
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/dcns.2019.21.1/nscarmeas
Pharmacological treatment of cognitive deficits in nondementing mental health disorders\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/trobbins
Psychedelic drugs—a new era in\u2028psychiatry?\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/dnutt
The epigenetics of perinatal stress\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.4/mszyf
Antidiabetic therapies and Alzheimer disease
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/dnc.2019.21.1/bbendlin
Treating psychiatric symptoms and disorders with non-psychotropic medications\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/vhede
Potential immunotherapy for Alzheimer disease and age-related dementia
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/dcns.2019.21.1/mschwartz
Epigenetics and depression\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.4/ebinder
Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/amccleery
Metacognitive and cognitive-behavioral interventions for psychosis: new developments\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/smoritz
Cognition and addiction\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/gdom
The synaptic pathology of cognitive life\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/whoner
Dementia prevention and reserve against neurodegenerative disease
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.1/RPERNECZKY2
What are we trying to prevent in Alzheimer disease?
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.1/FJESSEN
Physical activity for cognitive health: what advice can we give to older adults with subjective cognitive decline and mild cognitive impairment?
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/dcns.2019.21.1/nlautenschlager
Effects of computer gaming on cognition, brain structure, and function: a critical reflection on existing literature\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/skuehn
Genomics and the future of psychopharmacology: MicroRNAs offer novel therapeutics\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/dgurwitz
Drug discovery in psychopharmacology: from 2D models to cerebral organoids\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/jladewig
Ethical issues in early diagnosis and prevention of Alzheimer disease
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/dnc.2019.21.1/pwhitehouse
Epigenetics as a key link between psychosocial stress and aging: concepts, evidence, mechanisms\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.4/azannas
Assessing behavior and cognition in rodents, nonhuman primates, and humans: where are the limits of translation?\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/mrossner
The “systems approach” to treating the brain: opportunities in developmental psychopharmacology\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/lloiacono
Receptor variants and the development of centrally acting medications\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/dbertrand
Prevention of dementia presents a potentially critical platform for improvement of long-term public health
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/dcns.2019.21.1/mbeeri
Transcriptional mechanisms of drug addiction\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.4/pkenny
Is Alzheimer disease a failure of mobilizing immune defense? Lessons from cognitively fit oldest-old
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/dcns.2019.21.1/vharoutunian
Dementia treatment versus prevention
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/dnc.2019.21.1/rperneczky
Genetic and epigenetic editing in\u2028nervous system\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.4/jday
Nonpharmacological treatment of dyscognition in schizophrenia: effects \u2028of aerobic exercise\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/aschmitt
Use of the epigenetic toolbox\u2028to contextualize common variants associated with schizophrenia risk\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.4/sakbarian
Dysfunctional neurocognition in individuals with clinically significant psychopathic traits\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/rblair
Future paths in psychopharmacology\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/fthibaut
Harnessing the microbiota to treat neurological diseases\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/nsurana
How evolutionary psychiatry can advance psychopharmacology\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/rnesse
Opportunities and challenges in psychopharmacology\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/pschulz
Is dementia a preventable disease ?
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/dcns.2019.21.1/fthibaut
Cognition in psychiatry\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/fthibaut
Epigenetics: the missing link between genes and psychiatric disorders?\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.4/fthibaut

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
88.89%100%--

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q1区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
NEUROSCIENCES
Q1

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学2区
NEUROSCIENCES 神经科学
2区
2023年12月升级版
医学2区
NEUROSCIENCES 神经科学
2区
2022年12月旧的升级版
医学2区
NEUROSCIENCES 神经科学
3区